Valuation: Omnicell, Inc.

Market Cap 1.68B 1.46B 1.36B 1.24B 2.34B 160B 2.38B 15.99B 6.27B 80.27B 6.31B 6.18B 268B P/E 2026 *
37.5x
P/E 2027 * 36.4x
Enterprise Value 1.68B 1.46B 1.36B 1.24B 2.34B 160B 2.38B 15.99B 6.27B 80.27B 6.31B 6.18B 268B EV / Sales 2026 *
1.36x
EV / Sales 2027 * 1.31x
Free-Float
76.33%
Yield 2026 *
-
Yield 2027 * -
1 day-1.21%
1 week-0.78%
Current month+4.21%
1 month-17.94%
3 months-14.87%
6 months-2.54%
Current year-18.63%
1 week 35.88
Extreme 35.88
37.75
1 month 34.86
Extreme 34.86
48.06
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
66.65
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 2002-09-30
Director of Finance/CFO 56 2025-09-14
President 50 2026-06-30
Director TitleAgeSince
Chairman 68 1992-08-31
Director/Board Member 70 2012-12-31
Director/Board Member 70 2013-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Sell

Chief Executive Officer

-10,000 0.0220%
7/1/26 Free

Chairperson

12,309 0.0271%
4/1/26 Free

Chief Administrative Officer

25,132 0.0553%
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%-0.78%+19.56%-44.53% 1.7B
+0.81%+11.67%-14.58%+21.88% 38.12B
+0.20%+1.29%-39.82%+162.08% 13.04B
+0.07%+0.89%-22.78%+68.34% 5.5B
+0.65%+8.28%-1.50% - 2.53B
-3.06%-0.07% - - 1.89B
+0.89%+0.37%-33.48% - 1.06B
+1.74%+5.66%+39.40%+128.92% 907M
-0.27%-0.54%-33.09%-45.40% 847M
+5.38%+5.38%+674.42%+974.19% 815M
Average +0.50%+82.44%+65.35%+180.78% 6.64B
Weighted average by Cap. +0.49%+190.56%-10.06%+67.61%

Financials

2026 *2027 *
Net sales 1.24B 1.07B 1B 916M 1.72B 118B 1.75B 11.77B 4.61B 59.05B 4.64B 4.54B 197B 1.29B 1.12B 1.05B 954M 1.79B 123B 1.82B 12.25B 4.8B 61.5B 4.84B 4.73B 205B
Net income 45.27M 39.23M 36.73M 33.51M 63.07M 4.32B 64.13M 431M 169M 2.16B 170M 166M 7.21B 47.37M 41.05M 38.43M 35.06M 65.98M 4.52B 67.09M 451M 177M 2.26B 178M 174M 7.54B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,485
Date Price Change Volume
26-08-11 US$36.86 -1.21% 464,847
26-08-10 US$37.31 +1.36% 529,257
26-08-07 US$36.81 +1.80% 754,895
26-08-06 US$36.16 -2.72% 503,213
26-08-05 US$37.17 +0.05% 699,654
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
36.86USD
Average target price
57.86USD
Spread / Average Target
+56.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock